What question did the researchers ask?
Randomised evidence on hormone replacement therapy was pooled across menopause symptom, quality-of-life, vaginal, bone and safety outcomes.
What did they actually find?
The analysis associated HRT with better menopause symptom and quality-of-life scores and improvements in vaginal and bone-health measures, without a significant pooled increase in treatment-emergent adverse events.
What should you keep in mind?
This is population-level menopause evidence. Individual benefit and risk depend on diagnosis, route, formulation, timing and medical history; testosterone, male hormone care and sexual-health concerns need their own evidence and assessment.
What does this mean for a Highfield consultation?
This is menopause evidence; testosterone-related care requires a separate diagnosis and evidence discussion. We consider that finding alongside independent guidance, your medical history, examination and priorities. It can support a better-informed decision, but it cannot promise a personal result or decide whether treatment is suitable.
Explore Specialist hormone therapy at Highfield ↗
